 |
|
|
 |
|
New Chemo Regimen May Benefit Ovarian Cancer Patients
|
 |  |  |  | Related Healthscout Videos |  |
|
Page: << Prev | 1 | 2 The study, published in an upcoming print issue of The Lancet, was released online Sunday to coincide with the European Cancer Organization meeting held Sept. 20 to 24 in Berlin.
"The use of such dose-dense therapy should be decided on an individual basis together with other options for women with advanced-stage ovarian cancer," Dr. Michael A. Bookman, of the Arizona Cancer Center in Tucson, wrote in an accompanying commentary in The Lancet.
More information
Text Continues Below

The U.S. National Cancer Institute has more about ovarian cancer.
Page: << Prev | 1 | 2
-- Robert Preidt
|
Copyright © 2009 ScoutNews, LLC. All rights reserved.
Last updated 9/20/2009
|
 |

SOURCE: The Lancet, news release, Sept. 19, 2009
|